Cutler Group LLC / CA - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$88
-99.9%
10,160
-59.5%
0.01%
-12.5%
Q3 2022$110,000
+307.4%
25,100
+31.4%
0.01%
+300.0%
Q2 2022$27,000
-87.2%
19,100
-16.0%
0.00%
-81.8%
Q1 2022$211,000
+1072.2%
22,730
+733.8%
0.01%
+1000.0%
Q4 2021$18,000
+1700.0%
2,726
+81.7%
0.00%
Q4 2020$1,000
-95.2%
1,500
+15.4%
0.00%
-100.0%
Q4 2019$21,000
+16.7%
1,300
-7.1%
0.00%
-50.0%
Q3 2019$18,0000.0%1,4000.0%0.00%0.0%
Q2 2019$18,000
-18.2%
1,4000.0%0.00%0.0%
Q1 2019$22,000
-21.4%
1,4000.0%0.00%
-33.3%
Q4 2018$28,000
-40.4%
1,400
-33.3%
0.00%0.0%
Q3 2018$47,000
-21.7%
2,100
-43.2%
0.00%
-40.0%
Q2 2018$60,000
+33.3%
3,700
+19.4%
0.01%
+25.0%
Q1 2018$45,000
-55.0%
3,100
-24.4%
0.00%0.0%
Q4 2017$100,000
+354.5%
4,100
+105.0%
0.00%
+300.0%
Q3 2017$22,000
-64.5%
2,000
-33.7%
0.00%
-50.0%
Q2 2017$62,000
-60.8%
3,016
-66.8%
0.00%
-66.7%
Q1 2017$158,000
-12.7%
9,090
-70.7%
0.01%
-14.3%
Q4 2016$181,000
-16.2%
30,990
-59.1%
0.01%
-30.0%
Q3 2016$216,000
+92.9%
75,690
-3.9%
0.01%
+100.0%
Q2 2016$112,000
-38.1%
78,746
+522.3%
0.01%
-58.3%
Q1 2016$181,000
-35.1%
12,654
-14.8%
0.01%
-25.0%
Q4 2015$279,00014,8540.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders